JAPAN-HEALTH-EBOLA-FUJIFILM-US-MERGER

Sales clerks wait for customers at their stall selling cosmetics made by Japan's Fujifilm in Tokyo on October 27, 2014. Fujifilm said it would buy a US vaccine maker as the Japanese firm increases its supply of an experimental Ebola drug to help stem the spread of the virus. The deal would see Fujifilm take a 49 percent stake in Kalon Biotherapeutics, with plans to buy the whole company "in the future", the company said, without supplying financial details. AFP PHOTO / Yoshikazu TSUNO (Photo by YOSHIKAZU TSUNO / AFP) (Photo by YOSHIKAZU TSUNO/AFP via Getty Images)
Sales clerks wait for customers at their stall selling cosmetics made by Japan's Fujifilm in Tokyo on October 27, 2014. Fujifilm said it would buy a US vaccine maker as the Japanese firm increases its supply of an experimental Ebola drug to help stem the spread of the virus. The deal would see Fujifilm take a 49 percent stake in Kalon Biotherapeutics, with plans to buy the whole company "in the future", the company said, without supplying financial details. AFP PHOTO / Yoshikazu TSUNO (Photo by YOSHIKAZU TSUNO / AFP) (Photo by YOSHIKAZU TSUNO/AFP via Getty Images)
JAPAN-HEALTH-EBOLA-FUJIFILM-US-MERGER
PURCHASE A LICENSE
How can I use this image?
$575.00
CAD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office.
Credit:
YOSHIKAZU TSUNO / Staff
Editorial #:
457935594
Collection:
AFP
Date created:
October 27, 2014
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
AFP
Barcode:
AFP
Object name:
Hkg10112350
Max file size:
2752 x 3858 px (9.17 x 12.86 in) - 300 dpi - 3 MB